Denali Therapeutics (DNLI) EBT Margin Growth (1y) (2019 - 2023)
Denali Therapeutics (DNLI) EBT Margin Growth (1y) (2019 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Denali Therapeutics | 4.37 Bn | 4.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -478,088.00 |
| Jun 30, 2023 | 17,433.00 |
| Mar 31, 2023 | -15,692.00 |
| Dec 31, 2022 | -83,097.00 |
| Sep 30, 2022 | -146,018.00 |
| Jun 30, 2022 | 29,263.00 |
| Mar 31, 2022 | 72,012.00 |
| Dec 31, 2021 | -23,343.00 |
| Sep 30, 2021 | -98,089.00 |
| Jun 30, 2021 | 60,519.00 |
| Mar 31, 2021 | 10.85 Mn |
| Dec 31, 2020 | 372,634.00 |
| Sep 30, 2020 | 44,650.00 |
| Jun 30, 2020 | 42,139.00 |
| Mar 31, 2020 | -10.85 Mn |
| Dec 31, 2019 | -371,047.00 |
| Sep 30, 2019 | 189,377.00 |
| Jun 30, 2019 | 188,945.00 |
| Mar 31, 2019 | 1.80 Mn |